Identification of novel therapeutic targets for pancreatic ductal adenocarcinoma through Drosophila phenotypic screening

被引：0
|
作者：
Sonoshita, M. [1 ]
机构：
[1] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114923
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB399
引用
收藏
页码：S154 / S154
页数：1
相关论文
共 50 条
  • [41] Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies
    Alla Kuznetsova
    Olga Popova
    Dmitry Panchenkov
    Tatyana Dyuzheva
    Alexey Ivanov
    Clinical and Experimental Medicine, 2023, 23 : 619 - 643
  • [42] GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets
    Sriram, Krishna
    Salmeron, Cristina
    Wiley, Shu Z.
    Insel, Paul A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2434 - 2455
  • [43] In silicoidentification of therapeutic compounds against microRNA targets in drug-resistant pancreatic ductal adenocarcinoma
    Aier, Imlimaong
    Semwal, Rahul
    Sharma, Anju
    Varadwaj, Pritish Kumar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (13): : 4893 - 4901
  • [44] Genes Associated with Epithelial-Mesenchymal Transition: Possible Therapeutic Targets in Ductal Pancreatic Adenocarcinoma?
    Hotz, Hubert G.
    Hotz, Birgit
    Buhr, Heinz-Johannes
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (05) : 448 - 454
  • [45] Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma
    Sekiya, Sho
    Fukuda, Junki
    Yamamura, Ryodai
    Ooshio, Takako
    Satoh, Yusuke
    Kosuge, Shinya
    Sato, Reo
    Hatanaka, Kanako C.
    Hatanaka, Yutaka
    Mitsuhashi, Tomoko
    Nakamura, Toru
    Matsuno, Yoshihiro
    Hirano, Satoshi
    Sonoshita, Masahiro
    CANCER RESEARCH, 2023, 83 (16) : 2704 - 2715
  • [46] 'Novel Drug Targets Based on Association between Inflammation and Pancreatic Ductal Adenocarcinoma' Reply
    Uomo, Ilaria
    Miraglia, Simona
    Pastorello, Maurizio
    JOURNAL OF THE PANCREAS, 2010, 11 (04): : 411 - 411
  • [47] Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma
    Roalso, Marcus T. T.
    Hald, Oyvind H.
    Alexeeva, Marina
    Soreide, Kjetil
    CANCERS, 2022, 14 (03)
  • [48] Identification of Inflammatory Subtypes of Pancreatic Ductal Adenocarcinoma
    不详
    PANCREAS, 2022, 51 (07) : 857 - 858
  • [49] Identification of metabolic changes in Pancreatic Ductal Adenocarcinoma
    Trajkovic-Arsic, M.
    Kalideris, E.
    Sun, N.
    Feuchtinger, A.
    Gupta, A.
    Aichler, M.
    Schmid, R. M.
    Walch, A.
    Siveke, J. T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 76 - 77
  • [50] Identification of therapeutic vulnerabilities in the subset of pancreatic ductal adenocarcinoma (PDAC) with homologous recombination deficiency
    Tesson, Mathias
    Kong, Kay
    Repsicak, Peter
    Bader, Aldo
    Hsieh, Ya-Ching
    Nourse, Craig
    Kirschner, Kristina
    Miller, Crispin
    Roberts, Ed
    Chang, David
    Morton, Jen
    CANCER RESEARCH, 2024, 84 (17)
12345